These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1188 related articles for article (PubMed ID: 32096747)

  • 1. Delirium Secondary to Lamotrigine Toxicity.
    Sanchez DL; Fusick AJ; Gunther SR; Hernandez MJ; Sullivan GA; Catalano MC; Catalano G
    Curr Drug Saf; 2020; 15(2):156-159. PubMed ID: 32096747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaze-evoked nystagmus associated with valproic acid-induced lamotrigine toxicity.
    Jung I; Shin JH; Kim J
    Clin Neurol Neurosurg; 2020 Sep; 196():106013. PubMed ID: 32623210
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delirium from valproic acid with lamotrigine.
    Mueller TH; Beeber AR
    Am J Psychiatry; 2004 Jun; 161(6):1128-9. PubMed ID: 15169707
    [No Abstract]   [Full Text] [Related]  

  • 5. [Secondary delirium due to the use of lamotrigine with abrupt increase valproic acid's dose].
    Rocha FF
    Braz J Psychiatry; 2008 Mar; 30(1):88. PubMed ID: 18373026
    [No Abstract]   [Full Text] [Related]  

  • 6. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
    Kaminow L; Schimschock JR; Hammer AE; Vuong A
    Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine drug interactions in combination therapy and the influence of therapeutic drug monitoring on clinical outcomes in paediatric patients.
    Koristkova B; Grundmann M; Brozmanova H; Kacirova I
    Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):26-33. PubMed ID: 30681278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
    Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
    Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine for people with borderline personality disorder: a RCT.
    Crawford MJ; Sanatinia R; Barrett B; Cunningham G; Dale O; Ganguli P; Lawrence-Smith G; Leeson VC; Lemonsky F; Lykomitrou-Matthews G; Montgomery A; Morriss R; Munjiza J; Paton C; Skorodzien I; Singh V; Tan W; Tyrer P; Reilly JG
    Health Technol Assess; 2018 Apr; 22(17):1-68. PubMed ID: 29651981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis.
    Benbadis S; Klein P; Schiemann J; Diaz A; Elmoufti S; Whitesides J
    Epilepsy Behav; 2018 Mar; 80():129-134. PubMed ID: 29414542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
    Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
    J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine-induced obsessive-compulsive disorder in patients with bipolar disorder.
    Sharma V; Doobay M
    CNS Spectr; 2019 Aug; 24(4):390-394. PubMed ID: 30086812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and prognostic markers for treatment response in generalized epilepsies.
    Gesche J; Hjalgrim H; Rubboli G; Beier CP
    Neurology; 2020 Nov; 95(18):e2519-e2528. PubMed ID: 32817177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
    Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS; Srinivasa R; Sadhotra A
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Sodium Valproate Combined with Lamotrigine on Quality of Life and Serum Inflammatory Factors in Patients with Poststroke Secondary Epilepsy.
    Tao S; Sun J; Hao F; Tang W; Li X; Guo D; Liu X
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104644. PubMed ID: 32081495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening organ failure after lamotrigine therapy.
    Ferguson LP; Dargan PI; Hood JL; Tibby SM
    Pediatr Neurol; 2009 May; 40(5):392-4. PubMed ID: 19380079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected interaction between quetiapine and valproate in patients with bipolar disorder.
    Huang CC; Wei IH
    Gen Hosp Psychiatry; 2010; 32(4):446.e1-2. PubMed ID: 20633751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.